−61.74 MILS
4.61 MILS
55.54 M
About CLAL BIOTECH
Sector
Industry
CEO
Assaf Segal
Website
Headquarters
Tel Aviv
Employees (FY)
146
Founded
1993
ISIN
IL0011042806
FIGI
BBG000QSGR48
Clal Biotechnology Industries Ltd. is a holding company which, engages in life sciences and medical technology research and development. It focuses on identifying and supporting innovative ventures, developing proprietary solutions, and addressing unmet medical needs. The company was founded on December 22, 1993 and is headquartered in Tel Aviv, Israel.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CBI is 45.0 ILA — it has increased by 0.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange CLAL BIOTECH stocks are traded under the ticker CBI.
CBI stock is 4.31% volatile and has beta coefficient of 0.30. Check out the list of the most volatile stocks — is CLAL BIOTECH there?
Yes, you can track CLAL BIOTECH financials in yearly and quarterly reports right on TradingView.
CBI stock has risen by 5.63% compared to the previous week, the month change is a 4.90% rise, over the last year CLAL BIOTECH has showed a 31.30% decrease.
Today CLAL BIOTECH has the market capitalization of 70.58 M, it has decreased by 3.21% over the last week.
Like other stocks, CBI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CLAL BIOTECH stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 146.00 employees. See our rating of the largest employees — is CLAL BIOTECH on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CLAL BIOTECH technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CLAL BIOTECH stock shows the sell signal. See more of CLAL BIOTECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.